Pfizer Inc.

PFE

Healthcare

$25.31

6.80%Undervalued

Pfizer Inc. (PFE) is a Healthcare company that currently yields 6.80% — historically undervalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $24.34 and the overvaluation threshold at $44.94. Pfizer Inc. holds a quality score of 40/100 (Average), reflecting 9 consecutive years of dividend growth with a 131% payout ratio. The 5-year dividend CAGR stands at 3.6%.

PFE Dividend Yield History — Weiss Valuation

Underval. $24.34Overval. $44.94

Price

Undervalued band

Overvalued band

Why Now?

Pfizer Inc. is trading near its historical undervaluation band.

Current yield 6.8% vs historical max 7.1% (96% of maximum).

9 years of uninterrupted dividends.

Elevated payout ratio of 131%.

Dividend Compounder (DRIP)

Initial Investment

Horizon (years)

Div. CAGR (%)

Year 1 Income

$704

Year 10 Income

$1,958

Yield on Cost

21.47%

Total Income

$12,185

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Quality Score

Average

Payout Ratio0/25

Dividend Streak12/25

Growth (CAGR 5Y)8/20

Yield vs History15/15

FCF Coverage5/15

Key Metrics

Current Price$25.31

Annual Dividend$1.72

Current Yield6.80%

Yield — Max (10Y)7.07%

Yield — Min (10Y)3.83%

Undervalued Below$24.34

Overvalued Above$44.94

Payout Ratio131.30%

CAGR Dividend 5Y3.6%

CAGR Dividend 10Y—

Years No Cut9y

consecutive years of dividend growth

In-depth analysis

→ PFE Dividend Analysis Article